The Snoo just received a key FDA sign-off. Here's what the approval means.
The FDA classification doesn't mean the Snoo can be marketed as a way to reduce the risk of SIDS — but it can state that it's proven to keep babies sleeping on their back, which in turn has been shown to protect against SIDS.
"Just as infant seats dramatically improve car safety, we hope to dramatically improve sleep safety by keeping babies on the back and reducing risky rolling," said Harvey Karp, MD, co-founder and CEO of Happiest BabyAnother possible benefit: now that the Snoo has been deemed a medical device by the government agency, it may become a free benefit provided by many health insurance programs, much like breast pumps are now.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
The SNOO Smart Sleeper Receives FDA ApprovalThe smart bassinet has officially become the first and only medical device to receive De Novo classification from the FDA for its ability to keep sleeping babies safely on their backs.
Les mer »
FDA plans to allow a second updated COVID booster for vulnerable AmericansThe FDA plans to allow older and immunocompromised Americans to get a second updated coronavirus booster shot in the near future, an acknowledgment of the virus’s continuing risks to vulnerable people.
Les mer »
FDA inspection finds sterilization issues at recalled eye drop manufacturer's facility | CNNThe manufacturer of eye drops that have been linked to an outbreak of serious bacterial infections in the US, including at least three deaths, did not follow proper protocol to prevent contamination of its products, according to an inspection report published Friday by the US Food and Drug Administration.
Les mer »
FDA inspection finds sterilization issues at recalled eye drop manufacturer's facilityAn 11-day inspection resulted in 11 observations by the FDA, including a 'manufacturing process that lacked assurance of product sterility.'
Les mer »
FDA inspection finds sterilization issues at recalled eye drop manufacturer's facilityAn 11-day inspection resulted in 11 observations by the FDA, including a 'manufacturing process that lacked assurance of product sterility.'
Les mer »
FDA inspection finds sterilization issues at recalled eye drop manufacturer's facilityAn 11-day inspection resulted in 11 observations by the FDA, including a 'manufacturing process that lacked assurance of product sterility.'
Les mer »